Johnson & Johnson (JNJ)
244.55
+3.69
(+1.53%)
USD |
NYSE |
Feb 12, 16:00
244.75
+0.20
(+0.08%)
After-Hours: 20:00
Johnson & Johnson EPS Diluted (Quarterly) : 2.098 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.45 |
| Gilead Sciences, Inc. | 1.74 |
| Eli Lilly & Co. | 7.390 |
| Merck & Co., Inc. | 1.191 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.116B |
| Revenue (Quarterly) | 24.56B |
| Total Expenses (Quarterly) | 19.45B |
| Enterprise Value | 616.43B |
| Gross Profit Margin (Quarterly) | 72.39% |
| Profit Margin (Quarterly) | 20.83% |
| Earnings Yield | 4.52% |
| Operating Earnings Yield | 4.35% |
| Normalized Earnings Yield | 3.789 |